Search results
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
- Solutions
ICON experts can help to implement patient-centric,...
- Therapeutics
Driving paediatric clinical research forward and protecting...
- Insights
Digital Disruption Technologies that accelerate and improve...
- About ICON
About ICON. Healthcare Intelligence. Clinical Research....
- Contact
ICON regularly contributes thought leadership to industry...
- Careers
ICON Careers. We encourage our people to seize the...
- Global Office Locator
ICON regularly contributes thought leadership to industry...
- Investigators
The studies ICON conducts span all phases of the drug...
- Solutions
Home. Careers. Your big ideas can make a bold impact. Explore careers at ICON today. Careers in Full Service. We want to be the Clinical Research Organisation that drives more client projects to market or accelerated decision than anyone else in the industry. Careers in FSP.
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.
ICON is a leading provider of consulting and outsourced development and commercialisation services to the pharmaceutical, biotechnology, medical device and public health sectors. ICON has developed 18 of the world's top 20 best selling drugs and operates in 90+ locations in 45 countries.
Choosing ICON means a decision you can feel good about – we’ve been an integral part of bringing more than 70 life-changing drugs to market. For over 40 years, we’ve studied drugs in a variety of categories, from cancer to rare diseases. With that solid experience, you can feel confident about participating in a clinical study with us.
